GlassScriptPhysician profile
Laura R Vick
NPI 1508899642
$77,371.91
in general payments reported to CMS, 2019-2025
24 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,531 · 2020: $1,020 · 2021: $61.29 · 2022: $1,436 · 2023: $258 · 2024: $24K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Travel and Lodging: $9,380 · Consulting Fee: $7,788 · Food and Beverage: $2,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,563.75 |
| Travel and Lodging | $9,379.76 |
| Consulting Fee | $7,787.50 |
| Food and Beverage | $2,592.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $62,003.00 | 2024-2025 | Bovine Collagen |
| Convatec INC. | $8,292.14 | 2019-2025 | |
| Inari Medical, INC. | $1,840.01 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Hill-Rom Company, INC | $1,178.26 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,174.75 | 2020-2024 | |
| Stryker Corporation | $882.61 | 2020 | |
| Kerecis Limited | $402.76 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $364.19 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, Prevena, Activ.A.C. |
| Kci USA, INC. | $243.75 | 2019-2023 | V.A.C. Veraflo, V.A.C.Ulta, Activ.A.C. Ion Progress |
| Smith+Nephew, INC. | $197.93 | 2019-2023 | Regranex, Collagenase Santyl |
| Davol INC. | $167.92 | 2022 | |
| Medtronic, INC. | $142.69 | 2023 | Signia |
| Bioventus LLC | $75.14 | 2022 | |
| Urgo Medical North America, LLC | $72.52 | 2022 | |
| Reprise Biomedical, INC. | $67.29 | 2025 | Miro3d |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $48.76 | 2019 | |
| Hydrofera LLC | $41.99 | 2024 | Hydrofera Blue |
| Integra Lifesciences Corporation | $41.14 | 2019-2020 | |
| Puma Biotechnology, INC. | $40.74 | 2019 | |
| Medline Industries LP | $33.50 | 2021-2023 | |
| Abbvie INC. | $16.14 | 2021 | |
| Ethicon US, LLC | $15.58 | 2019 | |
| Aroa Biosurgery Incorporated | $15.43 | 2019 | |
| Kyowa Kirin, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Vick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.